PYRAZOLOPYRIMIDINE COMPOUND FOR TREATING ERECTILE DYSFUNCTION Russian patent published in 2015 - IPC C07D487/04 A61K31/519 A61P15/10 

Abstract RU 2555364 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to a compound (I) or its pharmaceutically acceptable salt, which possess properties of selective phosphodiesterase inhibitors, and can be used for treating male erectile dysfunction. In compound (I) R1 represents C1-C6alkyl; R2 represents C1-6alkyl; R3 represents C1-C6alkyl; R4 represents C1-C6 alkyl; R5 means H. The above salt is formed by the compound of formula (I) and an acid specified in citric acid, oxalic acid, hydrochloric acid, sulphuric acid, phosphoric acid, maleic acid, fumaric acid, tartaric acid, hydroxysuccinic acid, succinic acid, methane sulphonic acid or n-toluene sulphonic acid. A preferential compound is 5-[2-ethoxy-5-(4-methyl-1-homopiperazinylsulphonyl)]phenyl-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one.

EFFECT: preparing the pharmaceutically acceptable salt that possesses the properties of selective phosphodiesterase inhibitors.

7 cl, 1 tbl, 5 ex

Similar patents RU2555364C2

Title Year Author Number
PYRAZOLEPYRIMIDINONES FOR TREATMENT OF IMPOTENTS 1994
  • Piter Ehllis
  • Nikolas Kennet Terrett
RU2130776C1
METHOD FOR PREPARING DERIVATIVES OF PYRAZOLOPYRIMIDINONE FOR TREATMENT OF IMPOTENCY 2001
  • Joo Moo-Khi
  • Kim Von-Bae
  • Chang Min-Sun
  • Kim Soon-Khoe
  • Kim Dong-Sung
  • Bae Chul-Dzun
  • Kim Jong-Duk
  • Kim Eun-Kha
RU2236410C2
PIRAZILE PYRIMIDINONES FOR IMPOTENCY TREATMENT 1994
  • Ehllis Piter
  • Terrett Nikolas Kennet
RU2373938C9
NEW COMPOUND FOR IMPOTENCE TREATMENT 2002
  • Lju Baoshun'
RU2279433C2
METHOD FOR TREATING MALE PATIENTS FOR ERECTILE DYSFUNCTION AND HIGH LIBIDO 2001
  • Dadli Robert E.
RU2303981C2
DERIVATIVES OF 2-SUBSTITUTED PHENYL-5,7-DIHYDROCARBYL-3,7-DIHYDROPYRROLO[2,3-d]PYRIMIDIN-4-ONES, THEIR PREPARING AND PHARMACEUTICAL USING 2004
  • Van Junfehn
  • Chzhao Kehtszjun'
RU2323220C2
COMPOUND POSSESSING INHIBITORY ACTION ON PHOSPHODIESTERASE TYPE 5, AND METHOD FOR PREPARING IT 2010
  • Chzhan Nan'
  • Chzhun Zhun
RU2547465C2
PHARMACEUTICAL COMPOSITION, CONTAINING SILDENAFIL OR ALPROSTADIL, MINOXIDIL OR EUPHYLLIN, TESTOSTERON OR YOHIMBINE AND LIPOSOMES FOR LOCAL APPLICATION 2010
  • Klopotenko Leonid Leonidovich
RU2482847C2
DERIVATIVES OF 6,7-DIHYDRO-3H-OXAZOLO[3,4-α]PYRAZINE-5,8-DIONE 2011
  • Sacurai Sergio Luiz
  • Zaim Marcio Henrique
  • Touzarim Carlos Eduardo Da Costa
  • Keppler Artur Franz
  • De Nucci Gilberto
RU2581831C2
PYRAZOLOPYRIMIDINONES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF CYCLIC GUANOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE 1992
  • Ehndrju Simon Bell
  • Nikolas Kennet Terrett
RU2114113C1

RU 2 555 364 C2

Authors

Van Tszjan'Pin

Van Tszjan'Go

Dates

2015-07-10Published

2012-01-20Filed